JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:1101-1109, doi:10.1016/j.jacc.2005.05.072 (Published online 7 September 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antoniades, C.
Right arrow Articles by Stefanadis, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoniades, C.
Right arrow Articles by Stefanadis, C.

Genetic Polymorphism on Endothelial Nitric Oxide Synthase Affects Endothelial Activation and Inflammatory Response During the Acute Phase of Myocardial Infarction

Charalambos Antoniades, MD, Dimitris Tousoulis, MD, PhD, FACC*, Carmen Vasiliadou, BSc, MSc, Christos Pitsavos, MD, FACC, FESC, Christina Chrysochoou, MD, Demosthenis Panagiotakos, BSc, MSc, PhD, Costas Tentolouris, MD, FACC, FESC, Kyriakoula Marinou, MD, Nikolaos Koumallos, MD and Christodoulos Stefanadis, MD, PhD, FACC, FESC

Cardiology Department, Athens University Medical School, Hippokration Hospital, Athens, Greece



View larger version (17K):

[in a new window]
 
Figure 1 (a) Plasma levels of von Willebrand factor (vWF) were significantly higher during the acute phase of myocardial infarction in patients with GT+TT (open squares) compared with those with GG (filled diamonds) genotype (p < 0.01). One year after the event, plasma vWF was still higher in GT+TT compared with GG (p < 0.05), but there was no significant difference in vWF levels between genotypes in the control group (p = NS). Values are expressed as mean ± SEM. *p < 0.05 and **p < 0.01 vs. GG; {dagger}p < 0.05 and {ddagger}p < 0.01 vs. acute phase; §p < 0.05 vs. matched control patients (adjusted according to Bonferoni). (b) Serum levels of oxidized LDL (ox-LDL) were significantly higher during the acute phase of myocardial infarction in patients with GT+TT (open squares) compared with those with GG (filled diamonds) genotype (p < 0.05). Serum oxidized low-density lipoprotein (LDL) was not significantly different in GT+TT compared with GG in patients one year after the event or in matched control patients (p = NS). Values are expressed as mean ± SEM. *p < 0.05 vs. GG; {dagger}p < 0.05 and {ddagger}p < 0.01 vs. acute phase; ap < 0.05 vs. matched control patients (adjusted according to Bonferroni).

 


View larger version (15K):

[in a new window]
 
Figure 2 (a) Serum levels of interleukin (IL)-6 were significantly higher during the acute phase of myocardial infarction in patients with GT+TT (open squares) compared with those with GG (filled diamonds) genotype (p < 0.05). Serum IL-6 was not significantly different in GT+TT compared with GG in patients one year after the event or in control patients (p = NS). Values are expressed as mean ± SEM. *p < 0.05 vs. GG; {ddagger}p < 0.01 vs. acute phase; §p < 0.05 vs. matched control patients (adjusted according to Bonferoni). (b) Serum levels of interleukin-1b (IL-1b) were significantly higher during the acute phase of myocardial infarction compared with one year later (p < 0.01 for all genotypes), but there was no significant difference between patients with GT+TT (open squares) and GG (filled diamonds) genotype (p = NS). Serum IL-1b was not significantly different in GT+TT compared with GG in patients one year after the event or in matched control patients (p = NS). Values are expressed as mean ± SEM. {ddagger}p < 0.01 vs. acute phase; ap < 0.01 vs. matched control patients (adjusted according to Bonferroni).

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.